Henriksson F, Jönsson B
Centre for Health Economics, Stockholm School of Economics, Stockholm, Sweden.
J Intern Med. 1998 Dec;244(6):461-8.
To estimate the total cost of diabetes mellitus in Sweden in 1994 and to compare the cost structure with a former Swedish study and with American studies. The study also aims to investigate how the total cost is distributed between control of and complications of the disease.
In order to estimate the economic burden of diabetes mellitus in Sweden in 1994, the cost-of-illness method, based on the human capital theory, has been used. Both direct and indirect costs have been estimated using a prevalence approach and a 'top-down' method.
The economic burden of diabetes mellitus is estimated at 5746 MSEK (1US$ = 7.50 SEK) in Sweden in 1994. The direct costs are estimated at 2455 MSEK and constitute about 43% of the total cost. The indirect costs (production loss due to morbidity and premature mortality) were the dominant costs and amounted to 3291 MSEK, or 57% of total cost. Comparisons with a previous Swedish study from 1978 show some interesting results. Firstly, the distribution of direct and indirect costs is identical between the two studies. Secondly, the distribution of costs between management/control of the disease and complications was about the same, comparing the situation 16 years apart. Four American studies show a cost structure similar to the cost structure presented in this study.
The overall conclusion must be that very little has changed in the cost structure of diabetes in Sweden between 1978 and 1994.
估算1994年瑞典糖尿病的总成本，并将成本结构与瑞典以前的一项研究以及美国的研究进行比较。该研究还旨在调查总成本在疾病控制和并发症之间的分配情况。
为了估算1994年瑞典糖尿病的经济负担，采用了基于人力资本理论的疾病成本法。直接成本和间接成本均采用患病率方法和“自上而下”的方法进行估算。
1994年瑞典糖尿病的经济负担估计为57.46亿瑞典克朗（1美元 = 7.50瑞典克朗）。直接成本估计为24.55亿瑞典克朗，约占总成本的43%。间接成本（因病 morbidity 和过早死亡导致的生产损失）是主要成本，达32.91亿瑞典克朗，占总成本的57%。与瑞典1978年的一项先前研究相比显示出一些有趣的结果。首先，两项研究中直接成本和间接成本的分布相同。其次，相隔16年比较疾病管理/控制与并发症之间的成本分布情况大致相同。四项美国研究显示出与本研究中呈现的成本结构相似的成本结构。
总体结论必然是，1978年至1994年期间瑞典糖尿病的成本结构几乎没有变化。
